DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

NCT04775953 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

NIH

Sponsor class

Conditions

Staphylococcal Bacteraemia

Interventions

DRUG: Cefazolin
DRUG: Dalbavancin
DRUG: Daptomycin
DRUG: Nafcillin
DRUG: Oxacillin
DRUG: Vancomycin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)